{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:58:35Z","timestamp":1772121515873,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.pedneo.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T12:07:44Z","timestamp":1550923664000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate"],"prefix":"10.1016","volume":"60","author":[{"given":"Ekaterina","family":"Alexeeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Dvoryakovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Denisova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Sleptsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kseniya","family":"Isaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Chomahidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Fetisova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Mamutova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Alshevskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Gladkikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Moskalev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2019.02.003_bib1","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","article-title":"Focus on adverse events of tumour necrosis factor \u03b1 blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients","volume":"67","author":"Gerloni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pedneo.2019.02.003_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/keu339","article-title":"Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice","volume":"54","author":"Fortunet","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pedneo.2019.02.003_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/rheumatology\/ken024","article-title":"Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis","volume":"47","author":"Galarraga","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pedneo.2019.02.003_bib4","first-page":"CD012537","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents","volume":"8","author":"Eccleston","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pedneo.2019.02.003_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-12-29","article-title":"Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry","volume":"12","author":"Sobel","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.pedneo.2019.02.003_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/14397595.2013.844404","article-title":"Effect of Tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy","volume":"24","author":"Miyamae","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.pedneo.2019.02.003_bib7","first-page":"104","article-title":"Growth in juvenile idiopathic arthritis: the role of inflammation","volume":"29","author":"Gaspari","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pedneo.2019.02.003_bib8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00296-014-3022-2","article-title":"Growth abnormalities in children and adolescents with juvenile idiopathic arthritis","volume":"34","author":"Bechtold","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pedneo.2019.02.003_bib9","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/keq123","article-title":"Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis","volume":"49","author":"Billiau","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pedneo.2019.02.003_bib10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.38984","article-title":"Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase III trial","volume":"67","author":"De Benedetti","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pedneo.2019.02.003_bib11","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/art.27682","article-title":"Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis","volume":"62","author":"Giannini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pedneo.2019.02.003_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2013-304713","article-title":"Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients","volume":"63","author":"Watanabe","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.pedneo.2019.02.003_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/03009742.2012.758776","article-title":"Does modern treatment of early rheumatoid arthritis reduce the need for intra-articular glucocorticoids?","volume":"42","author":"Weitoft","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.pedneo.2019.02.003_bib14","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00296-011-2084-7","article-title":"Decreased use of non-steroidal anti-inflammatory drugs for the treatment of juvenile idiopathic arthritis in the era of modern aggressive treatment","volume":"32","author":"Kochar","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pedneo.2019.02.003_bib15","first-page":"7802957","article-title":"The pattern of juvenile idiopathic arthritis in a single tertiary center in Saudi Arabia","volume":"2016","author":"Al-hemairi","year":"2016","journal-title":"Int J Inflam"},{"key":"10.1016\/j.pedneo.2019.02.003_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1546-0096-11-3","article-title":"Treatment preferences in juvenile idiopathic arthritis \u2013 a comparative analysis in two health care systems","volume":"11","author":"Hugle","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.pedneo.2019.02.003_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12969-016-0126-0","article-title":"Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept","volume":"14","author":"Verazza","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.pedneo.2019.02.003_bib18","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957218303966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957218303966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:53:32Z","timestamp":1761749612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957218303966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1875957218303966"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2019.02.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735372850.793582474","asserted-by":"object"}]},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}